비스포스포네이트(Bisphosphonate)를 복용하는 환자에서 발생하는 골괴사증

다국어 초록 (Multilingual Abstract)

Bisphosphonates are widely used in the management of osteoporosis patients. Many reports and clinical studies have published a relationship between necrotic bone lesions localized to the jaw and the use of chronic bisphosphonate therapy. This osteonecrosis named bisphosphonate-related osteonecrosis of the jaw(BRONJ). This article described the mechanism, chemical structure, indication, risk factor of the bisphosphonate

목차 (Table of Contents)

• ABSTRACT
• I. 서론
• II. 결론
• 참고문헌

참고문헌 (Reference)

1 Green J, "The molecular basis of bisphosphonate activity: a preclinical perspective" 37 (37): S3-11, 2010

2 Rondeau JM, "Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs" 1 : 267-273, 2006

3 Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic" 61 : 1115-1117, 2003

4 Nase JB, "Osteonecrosis of the jaw and oral bisphosphonate treatment" 137 : 1115-1119, 2006

5 Fleisch H, "Development of bisphosphonates" 4 : 30-34, 2002

6 Green JR, "Bisphosphonates: preclinical review" 9 (9): 3-13, 2004

7 Fleisch H, "Bisphosphonates: mechanisms of action" 19 : 80-100, 1998

8 Ruggiero SL, "Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management" 60 : 85-96, 2009

9 Infante Cossio P, "Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma" 13 : 52-57, 2008

10 Gibbs SD, "Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention" 183 : 549-550, 2005

11 Kanat O, "Bisphosphonate treatment as a cause of jaw osteonecrosis" 13 : 346-347, 2007

12 Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update" 67 : 2-12, 2009